Vir Biotechnology, Inc. (VIR)
9.26
-0.22
(-2.32%)
USD |
NASDAQ |
Mar 13, 16:00
9.255
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Total Assets (Quarterly) : 1.025B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | 2.155B |
| BioMarin Pharmaceutical, Inc. | 7.594B |
| Xeris Biopharma Holdings, Inc. | 392.94M |
| Gossamer Bio, Inc. | 208.82M |
| Sensei Biotherapeutics, Inc. | 31.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 259.65M |
| Shareholders Equity (Quarterly) | 765.28M |
| Debt to Equity Ratio | 0.1279 |
| Current Ratio | 5.539 |
| Net Debt Paydown Yield | 0.36% |